Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum

Clinical trial NCT03971643 · COMPLETED

Trial details

NCT number: NCT03971643
Sponsor: InflaRx GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pyoderma Gangrenosum

Start date: 2019-05-16
Primary completion: 2022-01-03
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.